The move follows Kennedy’s repeated statements about pharma-backed CDC advisory panels. The Health and Human Services ...

An aide to U.S. Health Secretary Robert F. Kennedy Jr. is seeking more information about three vaccines recommended by a ...

CDC's RSV vaccine recommendations from Pfizer and GSK face review by HHS advisor William "Reyn" Archer III. Read more here.

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

Moderna plans to launch 10 new marketed products over the next three years, aiming to diversify a revenue base, which is ...

GlaxoSmithKline Pharmaceuticals Limited has announced that Sukanya Choudhury, Executive Vice President - Regulatory Affairs ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

MRNA reports mixed Q1 results. The company reiterates 2025 sales guidance but announces a cost-cutting initiative to reduce ...

GSK said it remains confident in its ability to absorb the financial impact of potential US pharmaceutical tariffs as it ...

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...

GSK’s dealmaking will be “cautious and disciplined” under the current trade war, but the pharma will focus on looking for ...